Rheumatoid Arthritis Synovial Fibroblasts on Fas-Induced Apoptosis α Effects of TNF-Metalloproteinases-3 Reverses the Inhibitory Gene Transfer of Tissue Inhibitor of Thomas

[1]  M. Bernardo,et al.  Differential Inhibition of Membrane Type 3 (MT3)-Matrix Metalloproteinase (MMP) and MT1-MMP by Tissue Inhibitor of Metalloproteinase (TIMP)-2 and TIMP-3 Regulates Pro-MMP-2 Activation* , 2004, Journal of Biological Chemistry.

[2]  S. Gay,et al.  Apoptosis in rheumatoid arthritis , 2003, Current opinion in rheumatology.

[3]  A. Newby,et al.  Tissue Inhibitor of Metalloproteinase-3 Induces a Fas-associated Death Domain-dependent Type II Apoptotic Pathway* , 2002, The Journal of Biological Chemistry.

[4]  I. Stamenkovic,et al.  CD44 anchors the assembly of matrilysin/MMP-7 with heparin-binding epidermal growth factor precursor and ErbB4 and regulates female reproductive organ remodeling. , 2002, Genes & development.

[5]  D. Easty,et al.  Adenovirus mediated gene delivery of tissue inhibitor of metalloproteinases-3 induces death in retinal pigment epithelial cells , 2002, The British journal of ophthalmology.

[6]  G. Bren,et al.  Transcription of the RelB gene is regulated by NF-κB , 2001, Oncogene.

[7]  J. Woessner.  That impish TIMP: the tissue inhibitor of metalloproteinases-3. , 2001, The Journal of clinical investigation.

[8]  H. Hsu,et al.  Regulation of tumor necrosis factor alpha-mediated apoptosis of rheumatoid arthritis synovial fibroblasts by the protein kinase Akt. , 2001, Arthritis and rheumatism.

[9]  Ye Zheng,et al.  NF-κB RelA (p65) Is Essential for TNF-α-Induced Fas Expression but Dispensable for Both TCR-Induced Expression and Activation-Induced Cell Death1 , 2001, The Journal of Immunology.

[10]  Patricia Renard,et al.  Development of a sensitive multi-well colorimetric assay for active NFκB , 2001 .

[11]  V. Knäuper,et al.  Localization of the Death Domain of Tissue Inhibitor of Metalloproteinase-3 to the N Terminus , 2000, The Journal of Biological Chemistry.

[12]  K. Brew,et al.  TIMP-3 Binds to Sulfated Glycosaminoglycans of the Extracellular Matrix* , 2000, The Journal of Biological Chemistry.

[13]  Thomas Pap,et al.  Fibroblast biology: Role of synovial fibroblasts in the pathogenesis of rheumatoid arthritis , 2000, Arthritis research.

[14]  R. Gay,et al.  Differential expression pattern of membrane-type matrix metalloproteinases in rheumatoid arthritis. , 2000, Arthritis and rheumatism.

[15]  D. Curiel,et al.  Gene therapy that inhibits nuclear translocation of nuclear factor κB results in tumor necrosis factor α–induced apoptosis of human synovial fibroblasts , 2000 .

[16]  E. Ohuchi,et al.  Production of tissue inhibitor of metalloproteinases 3 is selectively enhanced by calcium pentosan polysulfate in human rheumatoid synovial fibroblasts. , 2000, Arthritis and rheumatism.

[17]  K. Brew,et al.  Tissue inhibitors of metalloproteinases: evolution, structure and function. , 2000, Biochimica et biophysica acta.

[18]  Gillian Murphy,et al.  Shedding of Syndecan-1 and -4 Ectodomains Is Regulated by Multiple Signaling Pathways and Mediated by a Timp-3–Sensitive Metalloproteinase , 2000, The Journal of cell biology.

[19]  Thomas Pap,et al.  Activation of synovial fibroblasts in rheumatoid arthritis: lack of expression of the tumour suppressor PTEN at sites of invasive growth and destruction , 1999, Arthritis research.

[20]  Ingo Schmitz,et al.  Differential Modulation of Apoptosis Sensitivity in CD95 Type I and Type II Cells* , 1999, The Journal of Biological Chemistry.

[21]  J. Tschopp,et al.  Oncogenic Ras inhibits Fas ligand‐mediated apoptosis by downregulating the expression of Fas , 1999, The EMBO journal.

[22]  A. Baldwin,et al.  NF-kappaB activation provides the potential link between inflammation and hyperplasia in the arthritic joint. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[23]  Saito,et al.  Modulation by proinflammatory cytokines of Fas/Fas ligand‐mediated apoptotic cell death of synovial cells in patients with rheumatoid arthritis (RA) , 1998, Clinical and experimental immunology.

[24]  P. Slocombe,et al.  TNF‐α converting enzyme (TACE) is inhibited by TIMP‐3 , 1998 .

[25]  N. Miyasaka,et al.  Ceramide, a mediator of interleukin 1, tumour necrosis factor α, as well as Fas receptor signalling, induces apoptosis of rheumatoid arthritis synovial cells , 1998, Annals of the rheumatic diseases.

[26]  M. Barker,et al.  Localization of the Functional Domains of Human Tissue Inhibitor of Metalloproteinases-3 and the Effects of a Sorsby’s Fundus Dystrophy Mutation* , 1998, The Journal of Biological Chemistry.

[27]  P. Croucher,et al.  Human myeloma cells shed the interleukin‐6 receptor: inhibition by tissue inhibitor of metalloproteinase‐3 and a hydroxamate‐based metalloproteinase inhibitor , 1998, British journal of haematology.

[28]  V. Kähäri,et al.  Adenovirus-mediated gene delivery of tissue inhibitor of metalloproteinases-3 inhibits invasion and induces apoptosis in melanoma cells. , 1998, Cancer research.

[29]  S. Nagataki,et al.  Apoptosis induction in synovial fibroblasts by ceramide: in vitro and in vivo effects. , 1998, The Journal of laboratory and clinical medicine.

[30]  A. Baker,et al.  Divergent effects of tissue inhibitor of metalloproteinase-1, -2, or -3 overexpression on rat vascular smooth muscle cell invasion, proliferation, and death in vitro. TIMP-3 promotes apoptosis. , 1998, The Journal of clinical investigation.

[31]  T. Ochi,et al.  Membrane Fas Ligand Kills Human Peripheral Blood T Lymphocytes, and Soluble Fas Ligand Blocks the Killing , 1997, The Journal of experimental medicine.

[32]  T. Salo,et al.  Matrix Metalloproteinase-8 Is Expressed in Rheumatoid Synovial Fibroblasts and Endothelial Cells , 1997, The Journal of Biological Chemistry.

[33]  N. Colburn,et al.  TIMP-3 induces cell death by stabilizing TNF-alpha receptors on the surface of human colon carcinoma cells. , 1997, Cytokine.

[34]  S. Nagataki,et al.  TNF‐α‐mediated expression of membrane‐type matrix metalloproteinase in rheumatoid synovial fibroblasts , 1996, Immunology.

[35]  G. Butler,et al.  The Soluble Catalytic Domain of Membrane Type 1 Matrix Metalloproteinase Cleaves the Propeptide of Progelatinase A and Initiates Autoproteolytic Activation , 1996, The Journal of Biological Chemistry.

[36]  G. Starace,et al.  An N-terminal domain shared by Fas/Apo-1 (CD95) soluble variants prevents cell death in vitro. , 1996, Journal of immunology.

[37]  G. Firestein,et al.  Apoptosis in rheumatoid arthritis synovium. , 1995, The Journal of clinical investigation.

[38]  B. Franza,et al.  RelA/p65 is a molecular target for the immunosuppressive action of protein kinase A. , 1995, The EMBO journal.

[39]  G. Fiucci,et al.  Three functional soluble forms of the human apoptosis-inducing Fas molecule are produced by alternative splicing. , 1995, Journal of immunology.

[40]  P. Krammer,et al.  Identification of soluble APO-1 in supernatants of human B- and T-cell lines and increased serum levels in B- and T-cell leukemias. , 1995, Blood.

[41]  Matthew J. Brauer,et al.  Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule. , 1994, Science.

[42]  W. Schaffner,et al.  Rapid detection of octamer binding proteins with 'mini-extracts', prepared from a small number of cells. , 1989, Nucleic acids research.

[43]  J. Blenis,et al.  Characterization of a transformation-sensitive protein in the extracellular matrix of chicken embryo fibroblasts. , 1984, The Journal of biological chemistry.

[44]  F. Breedveld,et al.  Cartilage degradation and invasion by rheumatoid synovial fibroblasts is inhibited by gene transfer of TIMP-1 and TIMP-3 , 2003, Gene Therapy.

[45]  M. Bijl,et al.  Apoptosis and autoantibodies in systemic lupus erythematosus , 2001 .

[46]  A. Baker,et al.  Inhibition of invasion and induction of apoptotic cell death of cancer cell lines by overexpression of TIMP-3 , 1999, British Journal of Cancer.

[47]  H. Eibel,et al.  TNF-αα induces the transcription factor Egr-1, pro-inflammatory cytokines and cell proliferation in human skin fibroblasts and synovial lining cells , 1998, Rheumatology International.